|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 250.00 EUR | +0.52% |
|
-5.52% | +4.78% |
| Jul. 09 | UK Life Sciences Hits GBP3 Billion Investment Milestone | MT |
| Jul. 03 | Berenberg Updates Price Target, Estimates for UCB on Recent Pipeline Deals | MT |
| Market Cap | 47.59B 54.4B 43.89B 40.61B 77.07B 5,193B 78.36B 526B 206B 2,550B 204B 200B 8,833B | P/E 2026 * |
27x | P/E 2027 * | 21.2x |
|---|---|---|---|---|---|
| Enterprise Value | 47.32B 54.09B 43.64B 40.37B 76.63B 5,163B 77.91B 523B 205B 2,535B 203B 199B 8,782B | EV / Sales 2026 * |
5.55x | EV / Sales 2027 * | 4.7x |
| Free-Float |
61.59% | Yield 2026 * |
0.59% | Yield 2027 * | 0.6% |
Last Transcript: UCB
| 1 day | +0.52% | ||
| 1 week | -5.52% | ||
| Current month | -4.58% | ||
| 1 month | -4.69% | ||
| 3 months | -8.02% | ||
| 6 months | -1.88% | ||
| Current year | +4.78% |
| 1 week | 247.3 |  | 260.4 |
| 1 month | 243.3 | | 275.5 |
| Current year | 223 | | 289.5 |
| 1 year | 168.45 | | 289.5 |
| 3 years | 65.4 | | 289.5 |
| 5 years | 65.4 | | 289.5 |
| 10 years | 54.84 | | 289.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 2014-12-31 | |
Sandrine Dufour
DFI | Director of Finance/CFO | 59 | 2020-06-30 |
Alistair Henry
CTO | Chief Tech/Sci/R&D Officer | 59 | 2024-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 2011-12-31 | |
| Director/Board Member | 67 | 2014-12-31 | |
| Director/Board Member | 56 | 2014-04-23 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| Jan. 14 | Fiscal year | Executive/Senior Manager | 3,000 | 0.0015% | ||
| Jan. 14 | Buy | Director | 500 | 0.0003% | ||
| Jan. 14 | Fiscal year | Executive/Senior Manager | 3,000 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.52% | -5.52% | +46.80% | +219.12% | 53.98B | |
| +0.76% | +2.09% | +20.88% | -3.54% | 67.44B | |
| -2.79% | +32.50% | +32.50% | +32.50% | 41.77B | |
| -1.45% | +4.98% | -49.28% | -53.20% | 41.15B | |
| -0.72% | -7.96% | +49.53% | -27.69% | 29.58B | |
| +3.74% | -4.01% | +133.49% | -35.59% | 29.28B | |
| +1.07% | +1.42% | +72.47% | +90.95% | 23.43B | |
| +0.17% | +8.48% | +4.86% | +185.45% | 19.11B | |
| +1.14% | +2.26% | +68.00% | +135.40% | 16.82B | |
| +15.12% | +16.82% | +96.11% | +433.87% | 15.36B | |
| Average | +1.75% | +0.23% | +47.54% | +97.73% | 33.79B | |
| Weighted average by Cap. | +0.79% | -0.46% | +38.61% | +69.58% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.53B 9.75B 7.87B 7.28B 13.82B 931B 14.05B 94.24B 36.94B 457B 36.62B 35.83B 1,584B | 9.63B 11.01B 8.88B 8.22B 15.6B 1,051B 15.86B 106B 41.71B 516B 41.35B 40.45B 1,788B |
| Net income | 1.75B 2B 1.61B 1.49B 2.83B 191B 2.88B 19.3B 7.56B 93.63B 7.5B 7.34B 324B | 2.26B 2.59B 2.09B 1.93B 3.67B 247B 3.73B 25B 9.8B 121B 9.71B 9.5B 420B |
| Net Debt | -271M -310M -250M -231M -439M -29.6B -447M -3B -1.17B -14.54B -1.16B -1.14B -50.35B | -2.31B -2.64B -2.13B -1.97B -3.75B -252B -3.81B -25.54B -10.01B -124B -9.93B -9.71B -429B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-09 | €250.00 | +0.52% | 266,649 |
| 26-07-08 | €248.70 | -2.01% | 303,577 |
| 26-07-07 | €253.80 | -0.24% | 242,415 |
| 26-07-06 | €254.40 | -1.97% | 169,111 |
| 26-07-03 | €259.50 | -1.93% | 131,923 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- UCB Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
